triiodothyronine has been researched along with Bone Loss, Osteoclastic in 42 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Biochemical markers of bone remodelling were used to evaluate bone turnover in two types of autosomal dominant osteopetrosis (ADO) at baseline and during stimulation with triiodothyronine (T3)." | 7.70 | Biochemical markers of bone metabolism in benign human osteopetrosis: a study of two types at baseline and during stimulation with triiodothyronine. ( Bollerslev, J; Brixen, K; Djøseland, O; Grodum, E; Haug, E; Ueland, T, 1998) |
| "Serum calcium, phosphorus, total and bone-specific alkaline phosphatase, procollagen type 1-C peptide (PICP), osteocalcin, IL-6 and TNF-alpha measurements were performed and deoxypyridinoline (free DPD), calcium, phosphorus and creatinine levels were measured in fasting morning urine specimens of all hyperthyroid patients and all controls." | 3.71 | Bone remodelling markers and serum cytokines in patients with hyperthyroidism. ( Akalin, A; Alatas, O; Colak, O; Efe, B, 2002) |
| "Biochemical markers of bone remodelling were used to evaluate bone turnover in two types of autosomal dominant osteopetrosis (ADO) at baseline and during stimulation with triiodothyronine (T3)." | 3.70 | Biochemical markers of bone metabolism in benign human osteopetrosis: a study of two types at baseline and during stimulation with triiodothyronine. ( Bollerslev, J; Brixen, K; Djøseland, O; Grodum, E; Haug, E; Ueland, T, 1998) |
| "Serum osteocalcin (OC) and bone-specific alkaline phosphatase (B-ALP), reflecting bone formation, and urinary pyridinoline cross-link (Pyr) excretion, reflecting bone resorption, have been measured in 27 patients with hyperthyroidism and 30 age-matched controls using direct and novel immunoassays." | 3.69 | Markers of bone turnover in hyperthyroidism and the effects of treatment. ( Bertholin, A; Delmas, PD; Garnero, P; Riou, JP; Vassy, V, 1994) |
| "Triiodothyronine (T3) was administered to the two groups as 20 micrograms doses three times daily for 7 days." | 2.68 | Skeletal responsiveness to thyroid hormone is not altered at menopause. ( Charles, P; Eriksen, EF; Langdahl, BL; Loft, AG; Mosekilde, L; Møller, N; Weeke, J, 1996) |
| "Intense bone resorption is a natural phenomenon also observed in some teleosts, during reproductive migration and fasting." | 1.34 | Thyroid hormone-induced demineralisation of the vertebral skeleton of the eel, Anguilla anguilla. ( Aroua, S; Baloche, S; Dufour, S; Kacem, A; Lopez, E; Meunier, F; Rousseau, K; Sbaihi, M, 2007) |
| "Hyperthyroidism is characterized by accelerated bone turnover, caused from direct stimulation of bone cells by increased thyroid hormones." | 1.32 | Serum osteocalcin levels in hyperthyroidism before and after antithyroid therapy. ( Atay, A; Barsal, G; Erciyas, F; Hekimsoy, Z; Taneli, F, 2004) |
| "However, of patients with Graves' disease (GD) maintained on antithyroid drug (ATD) treatment, some exhibit persistent suppression of TSH long after normalization of their serum free T3 (FT3) and free T4 (FT4) levels." | 1.31 | Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism. ( Inaba, M; Ishikawa, T; Kumeda, Y; Kurioka, Y; Morii, H; Nishizawa, Y; Tahara, H, 2000) |
| " Dose-dependent inhibition of resorption was seen with SB-273005 after 7 days of dosing using Dpd as a measure of bone resorption." | 1.31 | Rapid inhibition of thyroxine-induced bone resorption in the rat by an orally active vitronectin receptor antagonist. ( Gowen, M; Hoffman, SJ; Lark, MW; Miller, WH; Stroup, G; Vasko-Moser, J, 2002) |
| "In mouse calvariae, the effect on bone resorption of the thyroid hormones is dependent on increased cellular replication, perhaps of osteoclast precursors, or other bone cells involved in the resorptive process." | 1.30 | Prostaglandin-independent stimulation of bone resorption in mouse calvariae and in isolated rat osteoclasts by thyroid hormones (T4, and T3). ( Conaway, HH; Lerner, UH; Ransjö, M, 1998) |
| "Thyroid hormones can stimulate bone resorption both directly and indirectly by increasing endogenous prostaglandin (PG) synthesis." | 1.29 | Comparison of the effects of 3,5,3'-triiodothyroacetic acid and triiodothyronine on bone resorption in cultured fetal rat long bones and neonatal mouse calvariae. ( Kawaguchi, H; Pilbeam, CC; Raisz, LG; Woodiel, FN, 1994) |
| "Pamidronate (APD) is a bisphosphonate that prevents bone loss from a variety of causes." | 1.29 | Parenteral pamidronate prevents thyroid hormone-induced bone loss in rats. ( Dresner-Pollak, R; Greenspan, SL; Gundberg, C; Hock, JM; Maitland, LA; Middlebrooks, VL; Moses, AC; Rosen, HN; Sullivan, EK; Zeind, AJ, 1993) |
| "To determine the effect of T3 on bone resorption, we used an isolated rat osteoclast bone resorption assay in the absence or presence of added osteoblasts." | 1.29 | Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. ( Britto, JM; Fenton, AJ; Holloway, WR; Nicholson, GC, 1994) |
| " In the dose-response studies, a biphasic increase in medium IGF-I was observed in both cells and limb bones, with peak stimulatory concentrations of 10(-8) M for T3 and 10(-7) M for T4 in both systems." | 1.29 | Thyroid hormones increase insulin-like growth factor I content in the medium of rat bone tissue. ( Caplice, MD; Khanna, V; Lakatos, P; Stern, PH, 1993) |
| "The serum P1CP levels of the untreated Graves' disease were significantly higher than in the controls (176." | 1.29 | Carboxy-terminal propeptide of type 1 procollagen (P1CP) and carboxy-terminal telopeptide of type 1 collagen (1CTP) as sensitive markers of bone metabolism in thyroid disease. ( Demura, H; Miyakawa, M; Tsushima, T, 1996) |
| "Tri-iodothyronine (T3) increases bone resorption in vivo and in vitro." | 1.28 | Tri-iodothyronine stimulates rat osteoclastic bone resorption by an indirect effect. ( Allain, TJ; Chambers, TJ; Flanagan, AM; McGregor, AM, 1992) |
| "At high doses, however, T3 stimulates bone resorption in a way similar to PTH." | 1.28 | The biphasic effect of triiodothyronine compared to bone resorbing effect of PTH on bone modelling of mouse long bone in vitro. ( Goldstein, M; Ornoy, A; Schwartz, Z; Soskolne, WA, 1990) |
| "Bone resorption was stimulated during the first week as evaluated from serum calcium and renal excretion of calcium, phosphate, and hydroxyproline." | 1.27 | Exogenous triiodothyronine activates bone remodeling. ( Charles, P; Eriksen, EF; Hasling, C; Mosekilde, L, 1987) |
| "Indomethacin did not inhibit T4 response suggesting that T4 stimulation of bone resorption was not mediated by increased prostaglandin synthesis by the cultured bone." | 1.26 | Direct stimulation of bone resorption by thyroid hormones. ( Bandelin, JG; Canalis, EM; Mundy, GR; Raisz, LG; Shapiro, JL, 1976) |
| " The dose-response curve for the thyroid gland factor was not parallel to that obtained using PTH and secretion was not under calcium control." | 1.26 | Secretion of a bone resorbing factor by chick thyroid glands in organ culture. ( Feinblatt, JD; Leone, RG; Tai, LR, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (26.19) | 18.7374 |
| 1990's | 20 (47.62) | 18.2507 |
| 2000's | 8 (19.05) | 29.6817 |
| 2010's | 3 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Southmayd, EA | 1 |
| Williams, NI | 1 |
| Mallinson, RJ | 1 |
| De Souza, MJ | 1 |
| Tsourdi, E | 1 |
| Rijntjes, E | 1 |
| Köhrle, J | 1 |
| Hofbauer, LC | 1 |
| Rauner, M | 1 |
| Monfoulet, LE | 1 |
| Rabier, B | 1 |
| Dacquin, R | 1 |
| Anginot, A | 1 |
| Photsavang, J | 1 |
| Jurdic, P | 1 |
| Vico, L | 1 |
| Malaval, L | 1 |
| Chassande, O | 1 |
| Fratzl-Zelman, N | 1 |
| Glantschnig, H | 1 |
| Rumpler, M | 1 |
| Nader, A | 1 |
| Ellinger, A | 1 |
| Varga, F | 1 |
| RAISZ, LG | 3 |
| Broulik, PD | 1 |
| Rosenkrancová, J | 1 |
| Růzicka, P | 1 |
| Sedlácek, R | 1 |
| Barsal, G | 1 |
| Taneli, F | 1 |
| Atay, A | 1 |
| Hekimsoy, Z | 1 |
| Erciyas, F | 1 |
| Sbaihi, M | 1 |
| Kacem, A | 1 |
| Aroua, S | 1 |
| Baloche, S | 1 |
| Rousseau, K | 1 |
| Lopez, E | 1 |
| Meunier, F | 1 |
| Dufour, S | 1 |
| Saraiva, PP | 1 |
| Teixeira, SS | 1 |
| Padovani, CR | 1 |
| Nogueira, CR | 1 |
| Walker, N | 1 |
| Jung, RT | 1 |
| Jennings, G | 1 |
| James, WP | 1 |
| Tarjan, G | 1 |
| Stern, PH | 2 |
| Bollerslev, J | 2 |
| Thomas, S | 1 |
| Grodum, E | 2 |
| Brixen, K | 2 |
| Djøseland, O | 2 |
| Rosen, HN | 3 |
| Dresner-Pollak, R | 2 |
| Moses, AC | 3 |
| Rosenblatt, M | 1 |
| Zeind, AJ | 2 |
| Clemens, JD | 1 |
| Greenspan, SL | 3 |
| Kawaguchi, H | 1 |
| Pilbeam, CC | 1 |
| Woodiel, FN | 1 |
| Garnero, P | 1 |
| Vassy, V | 1 |
| Bertholin, A | 1 |
| Riou, JP | 1 |
| Delmas, PD | 1 |
| Sullivan, EK | 1 |
| Middlebrooks, VL | 1 |
| Gundberg, C | 2 |
| Maitland, LA | 1 |
| Hock, JM | 1 |
| Britto, JM | 1 |
| Fenton, AJ | 1 |
| Holloway, WR | 1 |
| Nicholson, GC | 1 |
| Lakatos, P | 1 |
| Caplice, MD | 1 |
| Khanna, V | 1 |
| Kung, VT | 1 |
| Seyedin, SM | 1 |
| Chen, T | 1 |
| Holick, M | 1 |
| Langdahl, BL | 2 |
| Loft, AG | 2 |
| Møller, N | 2 |
| Weeke, J | 2 |
| Eriksen, EF | 3 |
| Mosekilde, L | 6 |
| Charles, P | 3 |
| Miyakawa, M | 1 |
| Tsushima, T | 1 |
| Demura, H | 1 |
| Conaway, HH | 1 |
| Ransjö, M | 1 |
| Lerner, UH | 1 |
| Yeo, PP | 1 |
| Loh, KC | 1 |
| Siddiqi, A | 1 |
| Burrin, JM | 1 |
| Wood, DF | 1 |
| Monson, JP | 1 |
| Ueland, T | 1 |
| Haug, E | 1 |
| Gürlek, A | 1 |
| Gedik, O | 1 |
| Kumeda, Y | 1 |
| Inaba, M | 1 |
| Tahara, H | 1 |
| Kurioka, Y | 1 |
| Ishikawa, T | 1 |
| Morii, H | 1 |
| Nishizawa, Y | 1 |
| Hoffman, SJ | 1 |
| Vasko-Moser, J | 1 |
| Miller, WH | 1 |
| Lark, MW | 1 |
| Gowen, M | 1 |
| Stroup, G | 1 |
| Akalin, A | 1 |
| Colak, O | 1 |
| Alatas, O | 1 |
| Efe, B | 1 |
| Lund, B | 1 |
| Sorensen, OH | 1 |
| Christensen, MS | 2 |
| Melsen, F | 3 |
| Atkins, D | 1 |
| Peacock, M | 1 |
| Mundy, GR | 1 |
| Shapiro, JL | 1 |
| Bandelin, JG | 1 |
| Canalis, EM | 1 |
| Bagger, JP | 1 |
| Myhre-Jensen, O | 1 |
| Schwartz Sorensen, N | 1 |
| Feinblatt, JD | 1 |
| Tai, LR | 1 |
| Leone, RG | 1 |
| Ohishi, T | 1 |
| Takahashi, M | 1 |
| Kushida, K | 1 |
| Horiuchi, K | 1 |
| Ishigaki, S | 1 |
| Inoue, T | 1 |
| Allain, TJ | 1 |
| Chambers, TJ | 1 |
| Flanagan, AM | 1 |
| McGregor, AM | 1 |
| Soskolne, WA | 1 |
| Schwartz, Z | 1 |
| Goldstein, M | 1 |
| Ornoy, A | 1 |
| Klaushofer, K | 1 |
| Hoffmann, O | 1 |
| Gleispach, H | 1 |
| Leis, HJ | 1 |
| Czerwenka, E | 1 |
| Koller, K | 1 |
| Peterlik, M | 1 |
| Hasling, C | 1 |
| Melcher, AH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "REFUEL Active Women's Study II: Increased Caloric Intake to Reverse Energy Deficiency in Exercising Women: Impact on Bone and Menstrual Cyclicity"[NCT00392873] | 233 participants (Actual) | Interventional | 2006-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for triiodothyronine and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Subclinical thyrotoxicosis.
Topics: Atrial Fibrillation; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Diagnosis, Different | 1998 |
4 trials available for triiodothyronine and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover.
Topics: Adolescent; Adult; Amino Acids; Analysis of Variance; Biomarkers; Bone Resorption; Calcium; Collagen | 1994 |
Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humans.
Topics: Adolescent; Adult; Amino Acids; Bone Resorption; Calcitriol; Calcium; Creatinine; Diphosphonates; Hu | 1993 |
Skeletal responsiveness to thyroid hormone is not altered at menopause.
Topics: Alkaline Phosphatase; Amino Acids; Blood Chemical Analysis; Blood Gas Analysis; Bone Density; Bone R | 1996 |
Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women.
Topics: Adult; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Female; Humans; Hyperthyroidism; P | 1999 |
37 other studies available for triiodothyronine and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Energy Deficiency Suppresses Bone Turnover in Exercising Women With Menstrual Disturbances.
Topics: Adult; Bone Density; Bone Remodeling; Bone Resorption; Cross-Sectional Studies; Energy Metabolism; E | 2019 |
Hyperthyroidism and Hypothyroidism in Male Mice and Their Effects on Bone Mass, Bone Turnover, and the Wnt Inhibitors Sclerostin and Dickkopf-1.
Topics: 3T3 Cells; Adaptor Proteins, Signal Transducing; Animals; Bone and Bones; Bone Density; Bone Marrow | 2015 |
Thyroid hormone receptor β mediates thyroid hormone effects on bone remodeling and bone mass.
Topics: Aging; Animals; Bone and Bones; Bone Density; Bone Remodeling; Bone Resorption; Hyperthyroxinemia; M | 2011 |
The expression of matrix metalloproteinase-13 and osteocalcin in mouse osteoblasts is related to osteoblastic differentiation and is modulated by 1,25-dihydroxyvitamin D3 and thyroid hormones.
Topics: Animals; Animals, Newborn; Bone Matrix; Bone Resorption; Calcitriol; Cell Differentiation; Collagena | 2003 |
BONE RESORPTION IN TISSUE CULTURE. FACTORS INFLUENCING THE RESPONSE TO PARATHYROID HORMONE.
Topics: Bone Resorption; Calcium; Calcium Isotopes; Edetic Acid; Hydrocortisone; Oxygen; Parathyroid Hormone | 1965 |
Effects of triiodothyronine and estrogen administration on bone mass, mineral content and bone strength in male rats.
Topics: Animals; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Estradiol; Hyperthyroidism; Male; | 2003 |
Serum osteocalcin levels in hyperthyroidism before and after antithyroid therapy.
Topics: Alkaline Phosphatase; Antithyroid Agents; Biomarkers; Bone Resorption; Calcium; Case-Control Studies | 2004 |
Thyroid hormone-induced demineralisation of the vertebral skeleton of the eel, Anguilla anguilla.
Topics: Anguilla; Animals; Bone Demineralization, Pathologic; Bone Density; Bone Resorption; Female; Osteopo | 2007 |
Triiodothyronine (T3) does not induce Rankl expression in rat Ros 17/2.8 cells.
Topics: Animals; Bone Resorption; Cell Differentiation; Electrophoresis, Agar Gel; Osteoblasts; Osteoclasts; | 2008 |
The effect of a beta-receptor agonist (salbutamol) on peripheral thyroid metabolism in euthyroid subjects.
Topics: Adult; Albuterol; Bone Resorption; Female; Humans; Kinetics; Triiodothyronine; Triiodothyronine, Rev | 1981 |
Triiodothyronine potentiates the stimulatory effects of interleukin-1 beta on bone resorption and medium interleukin-6 content in fetal rat limb bone cultures.
Topics: Animals; Bone Resorption; Culture Media; Drug Synergism; Interleukin-1; Interleukin-6; Limb Buds; Or | 1995 |
Collagen metabolism in two types of autosomal dominant osteopetrosis during stimulation with thyroid hormones.
Topics: Adult; Alkaline Phosphatase; Biomarkers; Bone Development; Bone Resorption; Collagen; Female; Fibrob | 1995 |
Comparison of the effects of 3,5,3'-triiodothyroacetic acid and triiodothyronine on bone resorption in cultured fetal rat long bones and neonatal mouse calvariae.
Topics: Animals; Aphidicolin; Bone and Bones; Bone Resorption; Calcitonin; Calcium; Fetus; Hydrocortisone; I | 1994 |
Markers of bone turnover in hyperthyroidism and the effects of treatment.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone | 1994 |
Parenteral pamidronate prevents thyroid hormone-induced bone loss in rats.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Animals; Body Weight; Bone Density; Bone Resorption; C | 1993 |
Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption.
Topics: Animals; Bone Resorption; Cytological Techniques; Osteoblasts; Osteoclasts; Rats; Rats, Sprague-Dawl | 1994 |
Thyroid hormones increase insulin-like growth factor I content in the medium of rat bone tissue.
Topics: Animals; Bone and Bones; Bone Resorption; Culture Media; Culture Techniques; Dose-Response Relations | 1993 |
Carboxy-terminal propeptide of type 1 procollagen (P1CP) and carboxy-terminal telopeptide of type 1 collagen (1CTP) as sensitive markers of bone metabolism in thyroid disease.
Topics: Adult; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Resorption; Collagen; Collagen Type I; | 1996 |
Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Topics: Absorptiometry, Photon; Administration, Oral; Aged; Alkaline Phosphatase; Amino Acids; Bone Density; | 1997 |
Prostaglandin-independent stimulation of bone resorption in mouse calvariae and in isolated rat osteoclasts by thyroid hormones (T4, and T3).
Topics: 6-Ketoprostaglandin F1 alpha; Acetylglucosaminidase; Animals; Bone Matrix; Bone Resorption; Calciton | 1998 |
Tri-iodothyronine regulates the production of interleukin-6 and interleukin-8 in human bone marrow stromal and osteoblast-like cells.
Topics: Bone Marrow Cells; Bone Resorption; Cell Line; Dose-Response Relationship, Drug; Humans; Interleukin | 1998 |
Biochemical markers of bone metabolism in benign human osteopetrosis: a study of two types at baseline and during stimulation with triiodothyronine.
Topics: Adult; Biomarkers; Bone and Bones; Bone Development; Bone Remodeling; Bone Resorption; Female; Genes | 1998 |
Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Antithyroid Agents; Autoantibodies; Biomarkers; Bone and B | 2000 |
Rapid inhibition of thyroxine-induced bone resorption in the rat by an orally active vitronectin receptor antagonist.
Topics: Amino Acids; Animals; Biomarkers; Bone Density; Bone Resorption; Male; Osteocalcin; Pyridines; Rats; | 2002 |
Bone remodelling markers and serum cytokines in patients with hyperthyroidism.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Autoantibodies; Biomarkers; Bone Resorption; Calcium; Case | 2002 |
Serum-25-hydroxycholecalciferol in hyperthyroidism.
Topics: Bone and Bones; Bone Resorption; Calcium; Humans; Hydroxycholecalciferols; Hyperthyroidism; Parathyr | 1977 |
A comparison of the effects of the calcitonins, steroid hormones and thyroid hormones on the response of bone to parathyroid hormone in tissue culture.
Topics: Animals; Bone and Bones; Bone Resorption; Calcitonin; Calcium; Carbohydrate Metabolism; Cholesterol; | 1975 |
Direct stimulation of bone resorption by thyroid hormones.
Topics: Animals; Bone and Bones; Bone Resorption; Cyclic AMP; Dose-Response Relationship, Drug; Female; Indo | 1976 |
Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calcium-phosphorus metabolism.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Bone and Bones; Bone Resorption; Calcium; Female; Hum | 1977 |
Interrelationships between bone morphometry, thyroid function tests and serum parathyroid hormone in hyperthyroidism.
Topics: Adult; Aged; Bone and Bones; Bone Resorption; Calcium; Creatinine; Humans; Hyperthyroidism; Iodine R | 1977 |
Secretion of a bone resorbing factor by chick thyroid glands in organ culture.
Topics: Animals; Bone Resorption; Calcitonin; Calcium; Chickens; Dose-Response Relationship, Drug; Drug Inte | 1976 |
Quantitative analyses of urinary pyridinoline and deoxypyridinoline excretion in patients with hyperthyroidism.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Resorption; Female; Humans; Hydroxyprolin | 1992 |
Tri-iodothyronine stimulates rat osteoclastic bone resorption by an indirect effect.
Topics: Animals; Bone Resorption; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Osteoclasts; | 1992 |
The biphasic effect of triiodothyronine compared to bone resorbing effect of PTH on bone modelling of mouse long bone in vitro.
Topics: Animals; Bone and Bones; Bone Development; Bone Resorption; Calcium; Calcium Radioisotopes; Mice; Or | 1990 |
Bone-resorbing activity of thyroid hormones is related to prostaglandin production in cultured neonatal mouse calvaria.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Animals, Newborn; Arachidonic Acid; Arachidonic Acids; Bone a | 1989 |
Exogenous triiodothyronine activates bone remodeling.
Topics: Adult; Aged; Bone Resorption; Calcium; Calcium-Binding Proteins; Female; Humans; Male; Middle Aged; | 1987 |
In vitro effect of oxygen, hydrocortisone and triiodothyronine on cells of Meckel's cartilage.
Topics: Animals; Bone Resorption; Cartilage; Hydrocortisone; In Vitro Techniques; Mandible; Mice; Oxygen; Tr | 1971 |